Vivimed Labs

quarterly
yearly
ParticularsDec '22Mar '23Jun '23Sep '23Dec '23
Revenue50.5739.7233.0132.4437.18
Expenses69.68306.6448.3951.9953.90
EBITDA-6.16-163.77-0.28-3.250.92
EBIT-9.96-258.84-4.77-7.74-3.56
Profit Before Tax-19.12-266.92-15.38-19.56-16.72
Net Profit-19.12-264.85-15.38-19.56-16.17
Financial Ratios
Operating Profit Margin-12.18%-412.31%-0.85%-10.73%2.48%
Net Profit Margin-37.82%-666.79%-46.61%-64.60%-43.54%
Earning Per Share (Diluted)-0.22-31.01-1.86-2.29-1.89
Dividends Per Share0.000.000.000.000.00
ⓒ 2016-2024 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 5.5.9
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ